We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Government enforcement agencies are increasing their scrutiny of deceptive advertising practices in the marketing divisions of device and diagnostics firms, an FTC official said June 20.
In observance of the Independence Day holiday, FDAnews Device Daily Bulletin will not be published Tuesday, July 4. The next issue will be published Wednesday, July 5.
SurModics, Inc., and AbbeyMoor Medical announced today the signing of an agreement to jointly develop products intended to site specifically deliver therapeutic agents to treat various diseases of the prostate, such as prostatitis and prostate cancer.
From pacifiers and diapers to medical devices that help care for preemies, Murrysville-based Respironics Inc. has carved out an unexpected niche selling baby products.
Raymedica today announced that it has received FDA approval to begin enrolling patients in a US clinical study to evaluate the potential benefits of its HydraFlex Nucleus Arthroplasty System, a new non-fusion technology for the treatment of degenerative disc disease.
Ophthalmic International, the wholly owned subsidiary of Coronado Industries, announced today the company has been granted a Medical Device License for its Pneumatic Trabeculoplasty (PNT) device by Health Canada.
Israel-based Dune Medical Devices has announced the closing of a $12.5 million Series B investment led by Apax Partners, who invested $11.5 million in the round.